SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$13.3B
1-Year Return
26.83%
This Quarter Return
+4.3%
1 Year Return
+26.83%
3 Year Return
+97.05%
5 Year Return
+189.63%
10 Year Return
–
AUM
$2.83B
AUM Growth
-$51.7M
(-1.8%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-4.02%
Top 10 Holdings %
Top 10 Hldgs %
16%
Holding
1,383
New
374
Increased
259
Reduced
316
Closed
422
Top Buys
| 1 |
NRG Energy
NRG
|
+$57.2M |
| 2 |
Vistra
VST
|
+$54.3M |
| 3 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$42.1M |
| 4 |
ConocoPhillips
COP
|
+$33.1M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$30.1M |
Top Sells
| 1 |
Conagra Brands
CAG
|
+$43.5M |
| 2 |
Target
TGT
|
+$32.7M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
+$30.4M |
| 4 |
Best Buy
BBY
|
+$28.2M |
| 5 |
Canadian Natural Resources
CNQ
|
+$22.9M |
Sector Composition
| 1 | Healthcare | 19.64% |
| 2 | Financials | 15.46% |
| 3 | Consumer Discretionary | 11.37% |
| 4 | Technology | 10.32% |
| 5 | Energy | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Realty Income
O
$54.6B
| $1.9M | 0.07% |
+28,483
| New | +$1.9M |
|
302
Surgery Partners
SGRY
$2.81B
| $1.89M | 0.07% |
+232,000
| New | +$1.89M |
|
303
Carisma Therapeutics
CARM
$16.4M
| $1.88M | 0.07% |
+62,785
| New | +$1.88M |
|
304
Roper Technologies
ROP
$55.8B
| $1.86M | 0.07% |
+5,080
| New | +$1.86M |
|
305
Equitable Holdings
EQH
$15.9B
| $1.86M | 0.07% |
88,900
-409,585
| -82% | -$8.56M |
|
|
RTLR
306
DELISTED
Rattler Midstream LP Common Units
RTLR
| $1.84M | 0.06% |
+94,629
| New | +$1.84M |
|
307
CSX Corp
CSX
$60.1B
| $1.82M | 0.06% |
70,467
-8,994
| -11% | -$232K |
|
308
Waste Connections
WCN
$45.7B
| $1.8M | 0.06% |
18,800
+264
| +1% | +$25.2K |
|
309
Northern Trust
NTRS
$24.5B
| $1.79M | 0.06% |
19,900
+10,547
| +113% | +$949K |
|
310
Humana
HUM
$31.3B
| $1.79M | 0.06% |
6,738
+5,396
| +402% | +$1.43M |
|
311
Regions Financial
RF
$24.1B
| $1.78M | 0.06% |
119,200
-60,900
| -34% | -$909K |
|
312
Abeona Therapeutics
ABEO
$348M
| $1.76M | 0.06% |
14,756
+6,000
| +69% | +$717K |
|
313
Coherus Oncology, Inc. Common Stock
CHRS
$156M
| $1.76M | 0.06% |
79,600
-177,100
| -69% | -$3.91M |
|
314
Trevi Therapeutics
TRVI
$1.07B
| $1.76M | 0.06% |
+234,442
| New | +$1.76M |
|
315
Royal Caribbean
RCL
$93.6B
| $1.76M | 0.06% |
14,500
-90,300
| -86% | -$10.9M |
|
316
Arvinas
ARVN
$584M
| $1.75M | 0.06% |
+79,700
| New | +$1.75M |
|
|
HZNP
317
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.75M | 0.06% |
+72,539
| New | +$1.75M |
|
318
Zymeworks
ZYME
$1.16B
| $1.74M | 0.06% |
+79,200
| New | +$1.74M |
|
319
Grifois
GRFS
$6.79B
| $1.74M | 0.06% |
82,500
-48,100
| -37% | -$1.02M |
|
320
Gildan
GIL
$8.11B
| $1.74M | 0.06% |
+44,900
| New | +$1.74M |
|
321
Valmont Industries
VMI
$7.44B
| $1.72M | 0.06% |
13,600
-700
| -5% | -$88.7K |
|
|
LK
322
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
| $1.72M | 0.06% |
+88,100
| New | +$1.72M |
|
|
ZEN
323
DELISTED
ZENDESK INC
ZEN
| $1.71M | 0.06% |
19,200
-3,800
| -17% | -$338K |
|
324
Keysight
KEYS
$29.3B
| $1.7M | 0.06% |
+18,952
| New | +$1.7M |
|
325
Arch Capital
ACGL
$33.7B
| $1.7M | 0.06% |
+45,900
| New | +$1.7M |
|